The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 9,576 | 98,970 | SH | SOLE | 98,970 | 0 | 0 | ||
ABBVIE INC | COM | 00287Y109 | 41,639 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 3,547 | 1,721,925 | SH | SOLE | 1,721,925 | 0 | 0 | ||
AGILENT TECHNOLOGIES INC | COM | 00846U101 | 41,088 | 338,030 | SH | SOLE | 338,030 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 6,777 | 303,500 | SH | SOLE | 303,500 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 32,364 | 239,150 | SH | SOLE | 239,150 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 16,988 | 75,370 | SH | SOLE | 75,370 | 0 | 0 | ||
BECTON DICKINSON & CO | COM | 075887109 | 14,023 | 62,930 | SH | SOLE | 62,930 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 18,677 | 69,950 | SH | SOLE | 69,950 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 64,344 | 759,038 | SH | SOLE | 759,038 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 2,880 | 455,000 | SH | SOLE | 455,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 6,892 | 104,600 | SH | SOLE | 104,600 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 37,127 | 958,600 | SH | SOLE | 958,600 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 15,864 | 223,150 | SH | SOLE | 223,150 | 0 | 0 | ||
CANO HEALTH INC | COM CL A | 13781Y103 | 3,430 | 395,560 | SH | SOLE | 395,560 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 23,418 | 300,970 | SH | SOLE | 300,970 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 5,246 | 266,830 | SH | SOLE | 266,830 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 21,340 | 76,910 | SH | SOLE | 76,910 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 12,508 | 131,150 | SH | SOLE | 131,150 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 21,054 | 434,560 | SH | SOLE | 434,560 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 30,427 | 117,800 | SH | SOLE | 117,800 | 0 | 0 | ||
DENTSPLY SIRONA INC | COM | 24906P109 | 4,485 | 158,200 | SH | SOLE | 158,200 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 20,417 | 253,500 | SH | SOLE | 253,500 | 0 | 0 | ||
ELEVANCE HEALTH INC | COM | 036752103 | 17,674 | 38,910 | SH | SOLE | 38,910 | 0 | 0 | ||
EQRX INC | *W EXP 12/17/202 | 26886C115 | 29 | 35,239 | SH | SOLE | 35,239 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 2 | 78,059 | SH | SOLE | 78,059 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 4,456 | 1,904,234 | SH | SOLE | 1,904,234 | 0 | 0 | ||
HENRY SCHEIN INC | COM | 806407102 | 16,371 | 248,920 | SH | SOLE | 248,920 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 8,861 | 137,330 | SH | SOLE | 137,330 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 14,206 | 229,530 | SH | SOLE | 229,530 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 20,824 | 42,920 | SH | SOLE | 42,920 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 2,227 | 2,749,400 | SH | SOLE | 2,749,400 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 781 | 220,082 | SH | SOLE | 220,082 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 6,214 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 15,184 | 227,851 | SH | SOLE | 227,851 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 6,783 | 38,240 | SH | SOLE | 38,240 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 1,529 | 85,230 | SH | SOLE | 85,230 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 13,842 | 1,607,650 | SH | SOLE | 1,607,650 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 939 | 1,066,689 | SH | SOLE | 1,066,689 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 33,354 | 103,150 | SH | SOLE | 103,150 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 16,654 | 328,030 | SH | SOLE | 328,030 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | *W EXP 99/99/999 | 54319Q113 | 10 | 149,999 | SH | SOLE | 149,999 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 11,909 | 35,040 | SH | SOLE | 35,040 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 1 | 29,776 | SH | SOLE | 29,776 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 5,466 | 272,890 | SH | SOLE | 272,890 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 9,084 | 27,540 | SH | SOLE | 27,540 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 2,854 | 65,130 | SH | SOLE | 65,130 | 0 | 0 | ||
NEOGENOMICS INC | COM NEW | 64049M209 | 3,367 | 391,110 | SH | SOLE | 391,110 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,307 | 21,720 | SH | SOLE | 21,720 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 3,150 | 67,600 | SH | SOLE | 67,600 | 0 | 0 | ||
ORION ACQUISITION CORP | *W EXP 02/19/202 | 68626A116 | 0 | 50,105 | SH | SOLE | 50,105 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 1,744 | 64,590 | SH | SOLE | 64,590 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 7,104 | 445,140 | SH | SOLE | 445,140 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 7,846 | 57,340 | SH | SOLE | 57,340 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 5,484 | 19,720 | SH | SOLE | 19,720 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 20,648 | 859,240 | SH | SOLE | 859,240 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 26,770 | 518,990 | SH | SOLE | 518,990 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 25,988 | 51,240 | SH | SOLE | 51,240 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 31,807 | 62,980 | SH | SOLE | 62,980 | 0 | 0 |